EPS Diluted (Annual) Chart

View EPS Diluted (Annual) for MDGEF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Annual) Chart
Start Trial

Historical EPS Diluted (Annual) Data

View and export this data back to 1997. Start Trial.
Date Value
December 31, 2023 -1.352
December 31, 2022 -0.6769
December 31, 2021 -0.9124
December 31, 2020 -2.545
December 31, 2019 -1.728
December 31, 2018 -2.009
December 31, 2017 -1.593
December 31, 2016 -1.008
December 31, 2015 -1.622
December 31, 2014 -1.184
December 31, 2013 -2.698
December 31, 2012 -2.635
December 31, 2011 1.796
December 31, 2010 -4.926
Date Value
December 31, 2009 -6.760
December 31, 2008 -10.12
December 31, 2007 -9.879
December 31, 2006 -2.956
December 31, 2005 -6.134
December 31, 2004 -8.494
December 31, 2003 -23.71
December 31, 2002 -24.78
December 31, 2001 -68.03
December 31, 2000 -7.677
December 31, 1999 0.00
December 31, 1998 0.00
December 31, 1997 0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
InflaRx NV -0.7654
BioNTech SE -5.305
Immatics NV -1.812
Arrowhead Pharmaceuticals, Inc. -0.0122
Oncolytics Biotech, Inc. -0.30